ロード中...
Monitoring therapeutic monoclonal antibodies in brain tumor
Bevacizumab induces normalization of abnormal blood vessels, making them less leaky. By binding to vascular endothelial growth factor, it indirectly attacks the vascular tumor mass. The optimal delivery of targeted therapies including monoclonal antibodies or anti-angiogenesis drugs to the target ti...
保存先:
| 出版年: | MAbs |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4622724/ https://ncbi.nlm.nih.gov/pubmed/25484065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.34405 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|